White House transparency disputes imperil funds to buy Covid therapeutics
WASHINGTON — The White House hasn’t publicly detailed exactly how it’s spent the more than $4 trillion Congress authorized for Covid-19 relief — and now, that lack of transparency could imperil its request for more money to fight the pandemic and buy therapeutics.
Amid heated negotiations over a government funding bill, three dozen Republican senators including Senate Minority Leader Mitch McConnell (R-Ky.) are refusing to consider more Covid-19 relief funding unless the federal government provides a full accounting of how funds have been spent.
Read Original Article: White House transparency disputes imperil funds to buy Covid therapeutics »
